# S-Equol in Alzheimer's Disease 2 Trial

> **NCT03101085** · PHASE1,PHASE2 · COMPLETED · sponsor: **Russell Swerdlow** · enrollment: 40 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** S-equol and Placebo
- **DRUG:** Placebo and S-equol

## Key facts

- **NCT ID:** NCT03101085
- **Lead sponsor:** Russell Swerdlow
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-05
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-03-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03101085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03101085, "S-Equol in Alzheimer's Disease 2 Trial". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03101085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*